Italia markets closed

Medtronic plc (MDT)

NYSE - Nasdaq Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
80,36-0,93 (-1,14%)
In data: 11:46AM EDT. Mercato aperto.
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente81,29
Aperto80,77
Denaro80,34 x 1800
Lettera80,36 x 900
Min-Max giorno80,01 - 80,83
Intervallo di 52 settimane68,84 - 92,02
Volume1.469.373
Media Volume6.380.977
Capitalizzazione106,71B
Beta (5 anni mensile)0,78
Rapporto PE (ttm)25,51
EPS (ttm)3,15
Prossima data utili23 mag 2024
Rendimento e dividendo (futuro)2,76 (3,40%)
Data ex dividendo21 mar 2024
Stima target 1A94,00
  • GlobeNewswire

    Gentherm Announces Dr. Ken Washington as New Independent Director

    NORTHVILLE, Mich., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ: THRM), the global market leader of innovative thermal management and pneumatic comfort technologies for the automotive industry and a leader in medical patient temperature management systems, today announced that Dr. Ken Washington has been appointed to the Company’s Board of Directors, effective October 2, 2023. Dr. Washington is the Senior Vice President, Chief Technology and Innovation Officer of Medtronic plc (NYSE: MDT),

  • GlobeNewswire

    Orchestra BioMed Granted FDA Approval of IDE to Initiate BACKBEAT Pivotal Study of BackBeat CNT™ for the Treatment of Hypertension in Pacemaker Patients

    Hypertension is the most common comorbidity in the pacemaker population, affecting over 70% of patients or approximately 750,000 people annually worldwideMedtronic plc and Orchestra BioMed have an exclusive strategic collaboration for global development and commercialization of BackBeat Cardiac Neuromodulation Therapy™ (CNT), now also known as Atrioventricular Interval Modulation (“AVIM”) therapy, for hypertensive pacemaker patientsBACKBEAT global pivotal study is expected to start before the en